Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001615219-25-000115
Filing Date
2025-08-26
Accepted
2025-08-26 16:07:39
Documents
13
Period of Report
2025-08-22
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20250822.htm   iXBRL 8-K/A 29576
2 EX-99.3 exhibit993-8xka.htm EX-99.3 382953
  Complete submission text file 0001615219-25-000115.txt   564509

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20250822.xsd EX-101.SCH 1807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20250822_lab.xml EX-101.LAB 22592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20250822_pre.xml EX-101.PRE 13078
16 EXTRACTED XBRL INSTANCE DOCUMENT flks-20250822_htm.xml XML 3143
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36812 | Film No.: 251257653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)